Interventions for Enhancing Adherence to Syphilis Treatment and Follow-up: Study Protocol for the Health Information and Monitoring of Sexually Transmitted Infections (SIM) Randomized Controlled Trial
- Conditions
- Syphilis
- Interventions
- Behavioral: follow-up by telephoneBehavioral: follow-up via a game in a smartphone appBehavioral: conventional follow-up by a health professional
- Registration Number
- NCT04753125
- Lead Sponsor
- Hospital Moinhos de Vento
- Brief Summary
The SIM study is a single-centre, randomized, controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance. The recruitment of participants will be done by invitation, and tests will be performed in a mobile unit in locations accessible to large populations. The goal is to perform 10,000 quick tests, with results confirmed by venereal disease research laboratory (VDRL) tests. Patients with a confirmed diagnosis according to VDRL test results will be randomized in one of three monitoring arms: follow-up by telephone, follow-up via a game in a smartphone app, or conventional follow-up by a health professional. All analyses will follow the intention-to-treat principle.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10000
- All adults aged 18 years and older with sorologic test positive for syphilis
- Participants who did not return after three contact attempts will be excluded from the study,
- pregnant women
- participants who are not able to provide contact information
- participants who are illiterate
- participants those who underwent syphilis treatment within the previous three months.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description compliance for blood test follow-up by telephone controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months. demographic socio-economic and sexuality questionnaire conventional follow-up by a health professional Questionnaire applied to all patients with positive VDRL compliance treatment follow-up by telephone controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months compliance treatment follow-up via a game in a smartphone app controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months compliance for blood test conventional follow-up by a health professional controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months. demographic socio-economic and sexuality questionnaire follow-up by telephone Questionnaire applied to all patients with positive VDRL compliance treatment conventional follow-up by a health professional controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance for 3, 6. 9 and 12 months compliance for blood test follow-up via a game in a smartphone app controlled trial with a 12-month follow-up period. The aim is to determine which of the 3 methods of follow-up is the most effective in promoting patient treatment compliance, follow-up via a game in a smartphone app through an interactive game with stimuli to pass the phase as the treatment was completed and blood tests were performed in 3,6,9 and 12 months. demographic socio-economic and sexuality questionnaire follow-up via a game in a smartphone app Questionnaire applied to all patients with positive VDRL
- Primary Outcome Measures
Name Time Method complince of treatment ut to 12 months (July 2023) 3 doses of penicillin g benzathine 3,000,000 UI. The injections are given in the gluteal region once a week from the first dose.
complince of exams up to 12 months (July 2023) Performing the VDRL blood test that should be done at 3, 6, 9 and 12 months after treatment with penicillin.
- Secondary Outcome Measures
Name Time Method identify behavioral risk factors for non-adherence to treatment upt to 12 months (July 2023) Identification of risk factors for non-adherence to treatment that will be carried out using a questionnaire applied to study participants with social, racial, sexual, economic and demographic issues.